274 related articles for article (PubMed ID: 33463006)
1. A novel prognostic mRNA/miRNA signature for esophageal cancer and its immune landscape in cancer progression.
Zhao Y; Xu L; Wang X; Niu S; Chen H; Li C
Mol Oncol; 2021 Apr; 15(4):1088-1109. PubMed ID: 33463006
[TBL] [Abstract][Full Text] [Related]
2. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
3. A Risk Model Based on Immune-Related Genes Predicts Prognosis and Characterizes the Immune Landscape in Esophageal Cancer.
Xie Y; Fu R; Xiao Z; Li G
Pathol Oncol Res; 2022; 28():1610030. PubMed ID: 35356506
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.
Yang H; Su H; Hu N; Wang C; Wang L; Giffen C; Goldstein AM; Lee MP; Taylor PR
BMC Cancer; 2020 May; 20(1):388. PubMed ID: 32375686
[TBL] [Abstract][Full Text] [Related]
5. Potential miRNA biomarkers for the diagnosis and prognosis of esophageal cancer detected by a novel absolute quantitative RT-qPCR method.
Lin Z; Chen Y; Lin Y; Lin H; Li H; Su X; Fang Z; Wang J; Wei Q; Teng J; Zhang Z
Sci Rep; 2020 Nov; 10(1):20065. PubMed ID: 33208781
[TBL] [Abstract][Full Text] [Related]
6. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
[TBL] [Abstract][Full Text] [Related]
7. An integrated analysis of the effects of microRNA and mRNA on esophageal squamous cell carcinoma.
Yang Y; Li D; Yang Y; Jiang G
Mol Med Rep; 2015 Jul; 12(1):945-52. PubMed ID: 25823933
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑200a promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through extensive target genes.
Yang B; Liu Y; Li L; Deng H; Xian L
Mol Med Rep; 2020 May; 21(5):2073-2084. PubMed ID: 32323771
[TBL] [Abstract][Full Text] [Related]
9. Potential Five-MicroRNA Signature Model for the Prediction of Prognosis in Patients with Wilms Tumor.
Gong Y; Zou B; Chen J; Ding L; Li P; Chen J; Chen J; Zhang B; Li J
Med Sci Monit; 2019 Jul; 25():5435-5444. PubMed ID: 31328722
[TBL] [Abstract][Full Text] [Related]
10. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
11. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.
Chen Z; Saad R; Jia P; Peng D; Zhu S; Washington MK; Zhao Z; Xu Z; El-Rifai W
Cancer; 2013 Jun; 119(11):1985-93. PubMed ID: 23456798
[TBL] [Abstract][Full Text] [Related]
12. Differential Analysis of lncRNA, miRNA and mRNA Expression Profiles and the Prognostic Value of lncRNA in Esophageal Cancer.
Liu H; Zhang Q; Lou Q; Zhang X; Cui Y; Wang P; Yang F; Wu F; Wang J; Fan T; Li S
Pathol Oncol Res; 2020 Apr; 26(2):1029-1039. PubMed ID: 30972633
[TBL] [Abstract][Full Text] [Related]
13. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel six autophagy-related genes signature for the prognostic and a miRNA-related autophagy predictor for anti-PD-1 therapy responses in prostate cancer.
Wu L; Quan W; Yue G; Luo Q; Peng D; Pan Y; Zhang G
BMC Cancer; 2021 Jan; 21(1):15. PubMed ID: 33402116
[TBL] [Abstract][Full Text] [Related]
15. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
16. microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival.
Wei Q; Li X; Yu W; Zhao K; Qin G; Chen H; Gu Y; Ding F; Zhu Z; Fu X; Sun M
J Cell Biochem; 2019 Aug; 120(8):12259-12272. PubMed ID: 31017699
[TBL] [Abstract][Full Text] [Related]
17. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
19. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of miRNA and target mRNAs in esophageal cancer.
Meng XR; Lu P; Mei JZ; Liu GJ; Fan QX
Braz J Med Biol Res; 2014 Sep; 47(9):811-7. PubMed ID: 25098614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]